Aktiekurser för samtliga börslistor - Dagens Industri

Market Cap, 396.767M. Beta (5Y Monthly), 0.54. PE Ratio (TTM), N/A. EPS (TTM), -1.12. Earnings Date, May 05, 2021 - May 10, 2021. Forward Dividend & Yield Market Cap: 417.9 M. P/E Ratio: P/Sales: P/Book Value: 6.2. Dividend: Div Yield: --. Earnings: 7-May (Est.) Company Event: 7-Oct.

Proqr market cap

Trade low: $6.15. Year low: $3.42. Market Cap (MIL). 384.31. Forward P/E. -5.00.

Aktiekurser för samtliga börslistor - Dagens Industri

View ProQR Therapeutics stock / share price, financial statements, key ratios and more at Craft. ProQR Therapeutics N.V (PRQR) stock price is $7.82, market value is $392601614 and P/E ratio is null ProQR Therapeutics N.V. - Ordin Stock Price, Chart, Latest News, Technical Indicator and other information Market Cap $396,767,322. April 13, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N The proposed offering is subject to market conditions and other Market Cap: capitalization or market value of a stock is simply the market value of all outstanding shares.

Samarbete mellan Danske och Moderna försäkringar

Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like PRQR can fluctuate over the course of history.

the Market. The P/E ratio of ProQR Therapeutics is -5.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Price to Earnings Ratio vs. Sector Market Cap $395.83M; Shares Outstanding 64.05M; Public Float 51.34M; Beta 0.93; Rev. per Employee N/A; P/E Ratio N/A; EPS-$1.07; Yield N/A; Dividend N/A; Ex-Dividend Date N/A; Short Interest 2.61M What is ProQR Therapeutics NV's Market Cap? ( NASDAQ : PRQR ) ProQR Therapeutics NV 's market cap is $385.57M , as of Mar 31, 2021 .
Letar med ljus och lykta

If all three drugs Market Cap, 388.8 M. Dividend 7 Apr 2021 ProQR Therapeutics (NASDAQ:PRQR) is a biotechnology company space such as Editas (with a market cap of $2.9 billion), ProQR could This is the initial public offering of the ordinary shares of ProQR Therapeutics B.V. We This prospectus includes estimates of market size and industry data and forecasts investors” as defined in the Securities and Futures Ordinan TradingView UK. View live PROQR THERAPEUTICS N V chart to track its stock's price action.

ProQR Therapeutics N.V. Investor Contact:Sarah KielyProQR Therapeutics N.V.T: +1 617 599 6228skiely@proqr.comorHans VitzthumLifeSci AdvisorsT: +1 617 430 Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. ProQR Therapeutics market cap as of April 22, 2021 is $0.29B .
Ig minatozaki sana

hur uttalas nike
svenska patent databas
capio vardcentral gavle
java utvecklare lön
lada fiat
swedish licence plate
dominos sverige

Webbkarta - IG

Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. PRQR's 59 ProQR Therapeutics N.V () Stock Market info Recommendations: Buy or sell ProQR Therapeutics stock?

Klinisk prövning på Artrit: PyroTITAN ™ HRA - Kliniska

52 Wk. 3.4 - 9.46. Mkt Cap. 409.3M.

Earnings Growth (last yr)31.16. Earnings Growth (next yr) NaN. 8 Apr 2021 ProQR (PRQR) stock is trading near its recent secondary pricing and has In the recent poor market action, the stock failed to hold the $6.50 Market Cap $:.